Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect

Neuroscience Letters

Volumn 368, Issue 1, 2004, Pages 82-86

  Doǧrul, Ahmet ^a   Gül, Hüsamettin ^a   Yildiz, Oǧuzhan ^a   Bilgin, Ferruh ^a   Güzeldemir, M Erdal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Allodynia; Analgesia; Cannabinoid; Diabetes mellitus; Hyperalgesia; Neuropathy

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; STREPTOZOCIN;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEAT SENSITIVITY; HOT PLATE TEST; HYPERALGESIA; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TAIL FLICK TEST;

ANIMALS; BEHAVIOR, ANIMAL; CANNABINOIDS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAT; MICE; MICE, INBRED BALB C; MORPHOLINES; NAPHTHALENES; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; REACTION TIME; RECEPTORS, CANNABINOID;

EID: 4444365789     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.060     Document Type: Article

References (41)

1. D. Bridges, A.S.C. Rice, M. Egertovác, M.R. Elphick, J. Winter, and G.J. Michael Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry Neuroscience 119 2003 803 812
2. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J. Neurosci. Methods 53 1994 55 63
3. S.R. Chen, and H.L. Pan Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats J. Neurophysiol. 87 2002 2726 2733
4. S.R. Chen, and H.L. Pan Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats Anesthesiology 99 2003 1409 1414
5. N.I. Cherny, H.T. Thaler, H. Friedlander-Klar, J. Lapin, K.M. Foley, R. Houde, and R.K. Portenoy Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies Neurology 44 1994 857 861
6. B. Costa, M. Colleoni, S. Conti, A.E. Trovato, M. Bianchi, M.L. Sotgiu, and G. Giagnoni Repeated treatment with the synthetic cannabinoid WIN 55, 212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain Br. J. Pharmacol. 141 2004 4 8
7. W.J. Dixon Efficient analysis of experimental observations Annu. Rev. Pharmacol. Toxicol. 20 1980 441 462
8. A. Dogrul, L.R. Gardell, S. Ma, M.H. Ossipov, F. Porreca, and J. Lai 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice Pain 100 2002 203 209
9. A. Dogrul, H. Gul, A. Akar, O. Yildiz, F. Bilgin, and E. Guzeldemir Topical cannabinoid antinociception: synergy with spinal sites Pain 105 2003 11 16
10. M.J. Field, S. McCleary, J. Hughes, and L. Singh Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat Pain 80 1999 391 398
11. A. Fox, C. Eastwood, C. Gentry, D. Manning, and L. Urban Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat Pain 81 1999 307 316
12. 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100
13. B.S. Galer, A. Gianas, and M.P. Jensen Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life Diabetes Res. Clin. Pract. 47 2000 123 128
14. L.R. Gardell, S.E. Burgess, A. Dogrul, M.H. Ossipov, T.P. Malan, J. Lai, and F. Porreca Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance Pain 98 2002 79 88
15. M.S. Gold Spinal nerve ligation: what to blame for the pain and why Pain 84 2000 117 120
16. H. Gul, O. Yildiz, A. Dogrul, O. Yesilyurt, and A. Isimer The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice Pain 89 2000 39 45
17. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. U.S.A. 87 1990 1932 1936
18. U. Herzberg, E. Eliav, G.J. Bennett, and I.J. Kopin The analgesic effect of R-(+) WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci. Lett. 221 1997 157 160
19. H.S. Huang, Q.H. Zhang, F.X. Bao, L. Lu, Y.J.C. Guo, L. Yang, W.J. Huang, G. Fu, S.H. Xu, X.P. Cheng, Q. Yan, Z.D. Zhu, X. Zhang, Z. Chen, Z.G. Han, and X. Zhang Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain Proc. Natl. Acad. Sci. U.S.A. 99 2002 8360 8365
20. A.G. Hohmann, E.M. Briley, and M. Herkenham Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord Brain Res. 822 1999 17 25
21. A.G. Hohmann, and M. Herkenham Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment Neurosci. Lett. 252 1998 13 16
22. L.J. Hudson, S. Bevan, G. Wotherspoon, C. Gentry, A. Fox, and J. Winter VR1 protein expression increases in undamaged DRG neurons after partial nerve injury Eur. J. Neurosci. 13 2001 2105 2114
23. A.R. Jadat, D. Carroll, C.J. Glynn, R.A. Moore, and H.J. McQuay Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia Lancet 339 1992 1367 1371
24. J. Kamei, Y. Ohhashi, T. Aoki, N. Kawasima, and Y. Kasuya Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists Brain Res. 571 1992 199 203
25. D. Kapur Neuropathic pain and diabetes Diabetes Met. Res. Rev. 19 2003 S9 S15
26. G.M. Khan, S.R. Chen, and H.L. Pan Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats Neuroscience 114 2002 291 299
27. S.T. Krishnan, and G. Rayman New treatments for diabetic neuropathy: symptomatic treatments Curr. Diab. Rep. 6 2003 3459 3467
28. J. Mao, D.D. Price, J. Lu, L. Keniston, and D.J. Mayer Two distinctive antinociceptive systems in rats with pathological pain Neurosci. Lett. 280 2000 13 16
29. M. Ohsawa, H. Mizoguchi, M. Narita, J. Kamei, H. Nagase, and L.F. Tseng Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice Eur. J. Pharmacol. 401 2000 55 58
30. M. Ohsawa, H. Nagase, and J. Kamei Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice J. Pharmacol. Exp. Ther. 286 1998 780 787
31. M.H. Ossipov, D. Bian, T.P. Malan, J. Lai, and F. Porreca Lack of involvement of capcaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats Pain 79 1999 127 1333
32. M.H. Ossipov, Y. Lopez, M.L. Nichols, D. Bian, and F. Porreca The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive Neurosci. Lett. 199 1995 87 90
33. Z. Rudich, J. Stinson, M. Jeavons, and S.C. Brown Treatment of chronic intractable neuropathic pain with dronabinol: case report of two adolescents Pain Res. Manage. 8 2003 221 224
34. D.A. Scott, C.E. Wright, and J.A. Angus Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat Pain 109 2004 124 131
35. H. Shuangsong, T.J. Morrow, P.E. Paulson, L.L. Isom, J.W. Wiley, Early diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat, J. Biol. Chem. (2004) in press.
36. G.S. Simon, and W.L. Dewey Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine J. Pharmacol. Exp. Ther. 218 1981 318 323
37. A. Ulugol, H.C. Karadag, M. Tamer, Z. Firat, A. Aslantas, and I. Dokmeci Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats Neurosci. Lett. 328 2002 129 132
38. C.P. Watson, D. Moulin, J. Watt-Watson, A. Gordon, and J. Eisenhoffer Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy Pain 105 2003 71 78
39. S.P. Welch, and M. Eads Synergistic interaction of endogenous opioids and cannabinoid systems Brain Res. 848 1999 183 190
40. O. Yesilyurt, A. Dogrul, H. Gul, M. Seyrek, O. Kusmez, Y. Ozkan, and O. Yildiz Topical cannabinoid enhances topical morphine antinociception Pain 105 2003 303 308
41. M. Zimmerman Ethical guidelines for investigation of experimental pain on conscious animals Pain 16 1983 109 110